Inflammatory bowel diseases (IBDs) are systemic diseases that manifest not only in the gut
and gastrointestinal tract, but also in the extraintestinal organs in many patients. The quality …

In this review, we provide an update on genome-wide association studies (GWAS) in
inflammatory bowel disease (IBD). In addition, we summarize progress in defining the …

Pyoderma gangrenosum (PG) is a rare inflammatory neutrophilic disorder with prototypical
clinical presentations. Its pathophysiology is complex and not fully explained. Recent …

Pyoderma gangrenosum is a challenging skin condition to identify and treat because of its
multifactorial pathogenesis. It is a rare cutaneous manifestation diagnosed clinically by …

This article reports on the sixth scientific workshop of the European Crohn's and Colitis
Organisation [ECCO] on the pathogenesis of extraintestinal manifestations [EIMs] in …

This is the second European Crohn's and Colitis Organisation [ECCO] evidence-based
consensus on extraintestinal manifestations [EIMs] of inflammatory bowel disease [IBD] and …

Introduction: Pyoderma gangrenosum (PG) is a complex neutrophilic dermatosis that can
occur as an idiopathic disease, in association with systemic conditions such as inflammatory …

The study of the genetic underpinnings of inflammatory bowel disease has made great
progress since the identification of NOD2 as a major susceptibility gene. Novel genotyping …

Inflammatory bowel disease (IBD) with its two main subtypes Crohn's disease and ulcerative
colitis is not restricted to the gastrointestinal tract. Indeed, so-called extraintestinal …

Background Peristomal pyoderma gangrenosum (PPG) is an uncommon subtype of
pyoderma gangrenosum. PPG is a challenging condition to diagnose and treat; no evidence …